94 related articles for article (PubMed ID: 273114)
41. [C monosomy changes in chronic myelocytic leukemia with special reference to response to therapy (author's transl)].
Sakurai Y; Nakao I
Rinsho Ketsueki; 1973 Nov; 14(11):1109-13. PubMed ID: 4522128
[No Abstract] [Full Text] [Related]
42. Phase I clinical evaluation of diaziquone in childhood cancer.
Ettinger LJ; Siegel SE; Belasco JB; Evans AE; Ruccione KS; Jamin DC; Rohrbaugh TM; Higgins GR
Cancer Treat Rep; 1985 Mar; 69(3):323-7. PubMed ID: 3856480
[TBL] [Abstract][Full Text] [Related]
43. [Early splenectomy as therapy for patients with chronic granulocytic leukaemia (author's transl)].
Pizzuto J; Rivas Llamas R; Echegoyen G; Morales MR
Sangre (Barc); 1975; 20(4):415-24. PubMed ID: 1062011
[No Abstract] [Full Text] [Related]
44. Clinical experience with a new anticancer agent, carbazilquinone (NSC-134679).
Saito T; Oira S; Wakui A; Yokoyama M; Takahashi H
Cancer Chemother Rep; 1973; 57(4):447-57. PubMed ID: 4586952
[No Abstract] [Full Text] [Related]
45. [On the treatment of hemoblastoses with N-diethyleneimidophosphonyl-N-phenylurea (C 73)].
Gerhartz H; Staeuber PG
Folia Haematol Int Mag Klin Morphol Blutforsch; 1965; 83(1):54-61. PubMed ID: 4157882
[No Abstract] [Full Text] [Related]
46. [A case of chronic myelogenous leukemia with atypical clinical course seen in a radiological worker (author's transl)].
Sato I; Endo K; Mikami M; Niikawa K; Sasaki T
Rinsho Ketsueki; 1977 Sep; 18(9):1143-9. PubMed ID: 271251
[No Abstract] [Full Text] [Related]
47. [A case of Ph1-positive chronic myelogenous leukemia with missing Y (author's transl)].
Joshita Y; Kubota K; Mizoguchi H; Kitagawa S; Sakamoto S; Oshimura M; Takaku F
Rinsho Ketsueki; 1978 Dec; 19(12):1641-5. PubMed ID: 283252
[No Abstract] [Full Text] [Related]
48. [The remission of the episode of myeloblasts with chronic myeloic leukemia in high age (author's transl)].
Twrdy E; Proszowski E
Aktuelle Gerontol; 1982 Jan; 12(1):26-8. PubMed ID: 6121503
[TBL] [Abstract][Full Text] [Related]
49. [Meningeosis leucaemica. Diagnosis and therapy (author's transl)].
Engelhardt P; Avenarius HJ; Lohmann E; Lorenz R
Nervenarzt; 1979 Apr; 50(4):245-53. PubMed ID: 287891
[No Abstract] [Full Text] [Related]
50. [A case of chronic myelogenous leukemia with a pericentric inversion of the heterochromatic region of chromosome No. 1 (author's transl)].
Ohyashiki K; Ohsumi A; Ito H; Umehara S; Ohyashiki J; Yamazaki T; Yunokawa K; Osamura S; Oshimura M
Rinsho Ketsueki; 1982 Feb; 23(2):199-205. PubMed ID: 6954301
[No Abstract] [Full Text] [Related]
51. [A new feasibility of immune stimulation in diseases with reduced cell immunity? (author's transl)].
Pavelka K; Müller W
Cas Lek Cesk; 1981 May; 120(19):566-70. PubMed ID: 7237501
[No Abstract] [Full Text] [Related]
52. [Blast crisis mimicking acute leukaemia as first manifestations of chronic myelogenous leukaemia. Report of three cases (author's transl)].
Cervantes F; Rozman C; Ballesta F; Brugues R; Grañena A; Montserrat E; Nomdedeu B
Sangre (Barc); 1981; 26(1):96-103. PubMed ID: 6942521
[No Abstract] [Full Text] [Related]
53. [A case of chronic myelogenous leukemia associated with operated gastric cancer (author's transl)].
Fujii H
Rinsho Ketsueki; 1978 Dec; 19(12):1677-83. PubMed ID: 283253
[No Abstract] [Full Text] [Related]
54. [Differing progress patterns in cancer of the uterine cervix and variant effects of adjuvant chemotherapy based on histological type].
Sugawa T; Yamagata S
Gan To Kagaku Ryoho; 1986 Feb; 13(2):210-5. PubMed ID: 3080962
[TBL] [Abstract][Full Text] [Related]
55. [Clinical experience with a new anticancer agent, carbazilquinone].
Saito T; Oira S; Wakui A; Yokoyama M; Takahashi H
Gan No Rinsho; 1971 Nov; 17(11):806-18. PubMed ID: 4947602
[No Abstract] [Full Text] [Related]
56. [Combination therapy of large amount of carboquone and OK-432 for unresectable lung cancer].
Nakarai I; Honda T; Jinnai S; Kita T; Shinoda A
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1006-11. PubMed ID: 7184436
[TBL] [Abstract][Full Text] [Related]
57. [Chronic myelogenous leukaemia with specific skin manifestations (author's transl)].
Díaz-Pérez JL; Moreno Benito J; Florián F; Chunchurreta RM
Sangre (Barc); 1980; 25(6):1099-1104. PubMed ID: 6939137
[No Abstract] [Full Text] [Related]
58. [Therapy of patients with myeloid leukemia with small doses of cytosine arabinoside].
Patterson D; Kravtsova VM; Petrova EM; Zabelina TS; Balaian LN
Ter Arkh; 1987; 59(12):81-6. PubMed ID: 3482131
[TBL] [Abstract][Full Text] [Related]
59. [Splenectomy in chronic myelogenous leukemia in Japan (author's transl)].
Shibata A
Rinsho Ketsueki; 1978 Apr; 19(4):400-8. PubMed ID: 279727
[No Abstract] [Full Text] [Related]
60. [Chronic myelogenous leukemia associated with marked lymphadenopathy in the terminal stage (author's transl)].
Yonemitsu H; Kanazawa S; Yamaguchi K; Okuda K; Baba M; Shigeta H; Takasago M
Rinsho Ketsueki; 1981 May; 22(5):653-60. PubMed ID: 6944515
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
